• K8凯发(中国)天生赢家·一触即发

    SCROLL
    About Hua Medicine

    Collaborative Innovation

    Hua Medicine is an innovative drug development and commercialization company based in Shanghai, China. Hua Medicine focused on developing novel therapies for patients worldwide with unmet medical needs. Based on global resources, Hua Medicine teams up with global high-caliber people to develop breakthrough technologies and products, which contribute a global innovation in diabetes care.

    2011
    Established
    70%
    R&D Team
    100+
    Clinical Center
    2011
    Established
    70%
    R&D Team
    100+
    Clinical Center
    Scientific R&D

    Research Area

    Glucokinase Activator(GKA) --- Dorzagliatin(HMS5552)is a first-in-class oral drug for the treatment of type 2 diabetes that under developed by Hua Medicine. Dorzagliatin has brand new mechanism and structure.
    mGluR5 negative allosteric modulators (NAM) as potential novel treatment for levodopa-induced dyskinesia in Parkinson’s disease (PD-LID) and plan to initiate clinical studies in the near future.
    Glucokinase Activator(GKA) --- Dorzagliatin(HMS5552)is a first-in-class oral drug for the treatment of type 2 diabetes that under developed by Hua Medicine. Dorzagliatin has brand new mechanism and structure.
    mGluR5 negative allosteric modulators (NAM) as potential novel treatment for levodopa-induced dyskinesia in Parkinson’s disease (PD-LID) and plan to initiate clinical studies in the near future.
    Type 2 Diabetes Therapy

    The Concept of Glucose Homeostasis

    &
    In Healthy Humans

    Glucose concentrations for healthy individuals are maintained within a narrow range of 4-6.5mM --- glucose homeostasis, and regulated by various pathways. As the glucose sensor, glucokinase (GK) senses changes in glucose levels, which is essential for maintaining whole-body glucose homeostasis.

    &
    In Patients with Type 2 Diabetes

    Impaired GK activity and function in T2D patients results in defects in glucose sensing, leading to disrupted glucose homeostasis.

    &
    Glucokinase Activator (GKA) Restores

    A GKA can repair defective GK function and restore glucose homeostasis.

    &
    In Healthy Humans

    Glucose concentrations for healthy individuals are maintained within a narrow range of 4-6.5mM --- glucose homeostasis, and regulated by various pathways. As the glucose sensor, glucokinase (GK) senses changes in glucose levels, which is essential for maintaining whole-body glucose homeostasis.

    &
    In Patients with Type 2 Diabetes

    Impaired GK activity and function in T2D patients results in defects in glucose sensing, leading to disrupted glucose homeostasis.

    &
    Glucokinase Activator (GKA) Restores

    A GKA can repair defective GK function and restore glucose homeostasis.

    GK
    Activity
    Media
    Focus Us
    Copyright © 2024  Hua Medicine (Shanghai) Co., Ltd.    互联网药品信息服务资格证书编号: (沪)-非经营-2022-0079
    沪ICP备14036654号-1  beiantubiao.png 沪公网安备 31011502013809号  Privacy Statement  Terms of Use
    Search
    How we use cookies
    Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our privacy statement.
    Accept
    x

    正在生成打印内容,请稍后重试。

    友情链接: